Cerebras Systems's April 17 Form S-1 refiling for a proposed Nasdaq listing under the ticker CBRS has reached the one-week mark. The pricing-range amendment — the document that fills in the blanks on the cover page — is the next artifact, and the opening of its filing window is the event Friday confirms. [1] The paper's Wednesday Day Three account carried the reading that the OpenAI-customer-lender-shareholder triangle has tightened, not loosened, since the refile. With the pricing window now open, the triangle moves from disclosure risk to valuation input.

The mechanics are specific. The April 17 prospectus lists Morgan Stanley, Citigroup, Barclays, and UBS as joint lead bookrunners, with Mizuho and TD Cowen as bookrunners, and Needham, Craig-Hallum, Wedbush, Rosenblatt, and Academy as co-managers. [2] Share count and offering price range are both blank on the cover and will be populated in a subsequent amendment. Cerebras's 2025 revenue reached $510 million, up 76 percent year over year; GAAP net income was $23.8 million, the first full-year profit in the company's public financials. [1] The counter-signal is concentration: 91 percent of accounts receivable at year-end 2024 came from G42, the single UAE customer whose presence triggered the October 2025 withdrawal. [2] CFIUS cleared the investment in 2025 and the company re-entered confidential DRS status in December, amended in March 2026, before going public on April 17.

OpenAI is the second concentration. The S-1 discloses a multi-year compute commitment now totaling more than $20 billion, a $1 billion working-capital loan at six percent annual interest repayable in cash or in goods and services, and warrants for up to 33,445,026 shares of Class N common stock at an exercise price of $0.00001 per share. [2] The warrant structure vests against purchase thresholds up to 2 gigawatts of compute. At a clearing valuation in the range several sell-side desks have floated — $7 billion to $9 billion equity value — OpenAI's fully-vested equity stake would represent roughly a tenth of the post-money float at effectively zero cost basis.

The pricing-window question is therefore not whether the book builds. It is at what valuation. The Saudi Aramco precedent is instructive: a 29-bank syndicate, a heavily-concentrated customer-base disclosure, and a final IPO that priced below the initial range after demand did not ratify the hoped-for level. Cerebras's bookrunners will test institutional demand against a revenue concentration — G42 historical, OpenAI forward — that is more acute than Aramco's. The ai-state-power thread the paper has kept through April runs through this document. The SpaceX $1.75T IPO roadshow ran parallel this week and ended its third analyst day without bank-commitment leaks. Cerebras is the smaller test of whether AI-hardware-layer public appetite holds. CBRS prices first.

Friday closes the first full calendar week of the public-window S-1. The next artifact is the S-1/A with dollar figures in place of blanks. The window for it is now open.

-- THEO KAPLAN, San Francisco